Classifications

• • A—HUMAN NECESSITIES
  • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
  • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
  • A61K49/00—Preparations for testing in vivo
  • A61K49/0004—Screening or testing of compounds for diagnosis of disorders, assessment of conditions, e.g. renal clearance, gastric emptying, testing for diabetes, allergy, rheuma, pancreas functions
• • A—HUMAN NECESSITIES
  • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
  • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
  • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
  • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
  • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
  • A61K47/62—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being a protein, peptide or polyamino acid
  • A61K47/64—Drug-peptide, drug-protein or drug-polyamino acid conjugates, i.e. the modifying agent being a peptide, protein or polyamino acid which is covalently bonded or complexed to a therapeutically active agent
  • A61K47/6425—Drug-peptide, drug-protein or drug-polyamino acid conjugates, i.e. the modifying agent being a peptide, protein or polyamino acid which is covalently bonded or complexed to a therapeutically active agent the peptide or protein in the drug conjugate being a receptor, e.g. CD4, a cell surface antigen, i.e. not a peptide ligand targeting the antigen, or a cell surface determinant, i.e. a part of the surface of a cell
• • C—CHEMISTRY; METALLURGY
  • C07—ORGANIC CHEMISTRY
  • C07K—PEPTIDES
  • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
  • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
  • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
  • C07K14/70571—Receptors; Cell surface antigens; Cell surface determinants for neuromediators, e.g. serotonin receptor, dopamine receptor
• • A—HUMAN NECESSITIES
  • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
  • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
  • A61K38/00—Medicinal preparations containing peptides

Landscapes

• Health & Medical Sciences (AREA)
• Life Sciences & Earth Sciences (AREA)
• Engineering & Computer Science (AREA)
• Chemical & Material Sciences (AREA)
• Proteomics, Peptides & Aminoacids (AREA)
• Bioinformatics & Cheminformatics (AREA)
• General Health & Medical Sciences (AREA)
• Toxicology (AREA)
• Molecular Biology (AREA)
• Gastroenterology & Hepatology (AREA)
• Epidemiology (AREA)
• Medicinal Chemistry (AREA)
• Animal Behavior & Ethology (AREA)
• Organic Chemistry (AREA)
• Public Health (AREA)
• Veterinary Medicine (AREA)
• Biomedical Technology (AREA)
• Cell Biology (AREA)
• Immunology (AREA)
• Urology & Nephrology (AREA)
• Genetics & Genomics (AREA)
• Pathology (AREA)
• Endocrinology (AREA)
• Pharmacology & Pharmacy (AREA)
• Neurology (AREA)
• Zoology (AREA)
• Biochemistry (AREA)
• Biophysics (AREA)
• Rheumatology (AREA)
• Diabetes (AREA)
• Peptides Or Proteins (AREA)
• Micro-Organisms Or Cultivation Processes Thereof (AREA)
• Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
• Preparation Of Compounds By Using Micro-Organisms (AREA)
• Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
• Saccharide Compounds (AREA)

Applications Claiming Priority (2)

Publications (1)

Family

ID=25187041

Family Applications (1)

Country Status (10)

Families Citing this family (18)

Family Cites Families (9)

• 1992
  • 1992-12-02 AT AT93900769T patent/ATE292175T1/de not_active IP Right Cessation
  • 1992-12-02 CA CA002101162A patent/CA2101162A1/en not_active Abandoned
  • 1992-12-02 JP JP5510317A patent/JPH06508764A/ja active Pending
  • 1992-12-02 AU AU32338/93A patent/AU672768B2/en not_active Expired
  • 1992-12-02 ES ES93900769T patent/ES2085246T1/es active Pending
  • 1992-12-02 EP EP93900769A patent/EP0585415B1/de not_active Expired - Lifetime
  • 1992-12-02 DE DE0585415T patent/DE585415T1/de active Pending
  • 1992-12-02 DE DE69233496T patent/DE69233496D1/de not_active Expired - Lifetime
  • 1992-12-02 WO PCT/US1992/010377 patent/WO1993011147A1/en active IP Right Grant
• 1995
  • 1995-01-09 US US08/370,542 patent/US5476782A/en not_active Expired - Lifetime
  • 1995-10-12 US US08/542,358 patent/US5786155A/en not_active Expired - Lifetime
• 1996
  • 1996-03-31 GR GR960300015T patent/GR960300015T1/el unknown
• 1998
  • 1998-02-04 US US09/018,351 patent/US6096507A/en not_active Expired - Fee Related

Also Published As

Similar Documents

Legal Events